Excitation-Contraction Coupling in Muscle
On this page
Direct answer
Skeletal muscle can contract with not a single calcium ion entering from outside the cell; cardiac muscle cannot. That contrast is the heart of excitation-contraction coupling: in skeletal muscle the dihydropyridine receptor (an L-type calcium channel) in the T-tubular membrane is mechanically docked to the ryanodine receptor RyR1 of the terminal cisterna, so tubular depolarisation physically pulls the calcium-release channel open — no calcium entry required, and contraction is immune to extracellular calcium over the short term. Cardiac myocytes instead use calcium-induced calcium release: the small calcium current through L-type channels (roughly 10-20% of the needed calcium) is the trigger, and RyR2 releases the bulk from the sarcoplasmic reticulum in direct proportion — which is why extracellular calcium, digoxin and heart rate all change cardiac contractility, while skeletal force depends on recruitment and frequency of firing instead. Relaxation is as designed as contraction: SERCA pumps, paced by phospholamban inhibition relieved by protein kinase A, resequester most of the calcium in the heart (about 70%), with the sodium-calcium extruder carrying much of the remainder.
What you must remember
- Triad anatomy: one T tubule flanked by two terminal cisternae at the A-I junction in mammalian skeletal muscle; dyads (one and one) in cardiac muscle, with T tubules at Z lines.
- Mechanical versus chemical coupling: skeletal DHPR conformationally gates RyR1 (fast, one action potential equals one contraction); cardiac L-type calcium entry gates RyR2 (graded, calcium-dependent amplification).
- Calcium source hierarchy: skeletal — internal stores only; cardiac — internal stores amplifying a trans-sarcolemmal trigger, so calcium influx is obligatory for every beat.
- Relaxation machinery: cardiac SERCA2a with phospholamban (phosphorylation relieves inhibition, speeding relaxation — the sympathetic inotropic and lusitropic effect), sodium-calcium exchanger extruding roughly a quarter, mitochondrial and sarcolemmal pumps minor.
- Pharmacology hooks: digoxin inhibits the sodium pump, raising intracellular sodium, blunting sodium-calcium exchange and loading the store with calcium; calcium channel blockers act on the cardiac trigger (negative inotropy) and on vascular smooth muscle L-type channels; dantrolene blocks RyR1.
- Disease anchors: malignant hyperthermia from RyR1 mutations under volatile anaesthetics and suxamethonium — sustained release, hyperthermia, treated by dantrolene; catecholaminergic polymorphic ventricular tachycardia from RyR2 mutations; muscular dysgenesis (DHPR loss) as the animal model of failed coupling.
- Frequency effects: skeletal force rises with repetitive firing through summation and tetanus (calcium reaccumulates between stimuli incompletely); cardiac muscle cannot tetanise because the action potential outlasts the mechanical refractory window — a protective design worth one full sentence.
Two patients, one molecular machine
A young man under hernia repair develops masseter spasm, climbing core temperature and rigid limbs after halothane and suxamethonium. The lesion is the skeletal machinery: a mutant RyR1 that opens under anaesthetic trigger and will not close, dumping sarcoplasmic calcium in cycles whose ATP cost generates the heat — hence dantrolene, which closes RyR1, is both mechanism and antidote, and the family is screened thereafter. Now the ward mirror: a patient with worsening heart failure on digoxin. His coupling is chemical — the sodium pump inhibition raises intracellular sodium, each beat's sodium-calcium exchange exports less calcium, the store loads, and RyR2 releases more per trigger: positive inotropy. Give too much and the overfilled store leaks in diastole (delayed afterdepolarisations, the classical bidirectional ventricular tachycardia of toxicity), while hypokalaemia potentiates it by starving the pump. One molecule family, two clinical languages — the exam's way of asking whether you understood coupling or memorised it.
Where students slip
Stating that "calcium binds troponin after entering through the tubule" is doubly wrong for skeletal muscle — the release is internal and mechanically triggered. Second, students apply cardiac pharmacology to skeletal force: no amount of extracellular calcium or digoxin meaningfully changes a healthy skeletal contraction's peak, because entry is not the trigger; frequency and recruitment govern it. Third, the phospholamban story is inverted: phosphorylation relieves phospholamban's inhibition of SERCA, so sympathetic stimulation speeds both contraction and relaxation (lusitropy) — candidates write only the inotropic half. Fourth, the reason the heart cannot tetanise is usually fudged; say it precisely — the prolonged action potential keeps fast sodium channels inactivated, so closely spaced stimuli cannot re-excite the membrane while calcium still cycles. Finally, do not call the dihydropyridine receptor merely a channel in skeletal muscle — its voltage-sensing role as the mechanical signal transducer is the whole point.
Frequently asked questions
How do skeletal and cardiac calcium release mechanisms differ?
Skeletal muscle couples the dihydropyridine receptor mechanically to RyR1, releasing calcium without calcium entry; cardiac muscle uses calcium-induced calcium release, where L-type channel entry triggers RyR2 to amplify the signal.
What is the triad of skeletal muscle?
One T tubule with two terminal cisternae of sarcoplasmic reticulum at the A-I junction, the structural arrangement placing the voltage sensor beside the release channel.
How does digoxin increase cardiac contractility?
Sodium pump inhibition raises intracellular sodium, reducing sodium-calcium exchange so intracellular calcium accumulates, enlarging the store released with each beat.
Which mutation causes malignant hyperthermia and what treats it?
Ryanodine receptor-1 mutations, triggered by volatile anaesthetics or suxamethonium, causing uncontrolled calcium release and hyperthermia; dantrolene blocks the receptor.
Why cannot cardiac muscle be tetanised?
Its long action potential and refractory period prevent closely spaced excitation while calcium cycling continues, protecting the heart from sustained contraction.